Published in J Pediatr on May 01, 1972
Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatr Nephrol (2011) 0.89
X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Arch Dis Child (1990) 0.76
[Hypophosphatemic diabetes and knee pain: does treatment with total knee arthroplasty promise success?]. Z Rheumatol (2009) 0.75
Serum C'3 lytic system in patients with glomerulonephritis. Science (1969) 4.44
Evidence for nuclear emissions during acoustic cavitation. Science (2002) 4.15
Nuclear emissions during self-nucleated acoustic cavitation. Phys Rev Lett (2006) 2.28
Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum. J Exp Med (1970) 2.08
Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis. J Clin Invest (1967) 1.90
A newly recognized dwarfing syndrome. Am J Dis Child (1969) 1.87
Paediatric sedation for CT scanning: the safety and efficacy of quinalbarbitone in a district general hospital setting. Br J Radiol (2000) 1.72
A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement. J Exp Med (1974) 1.63
Effect of diphenylhydantoin on the metabolism of dexamethasone. N Engl J Med (1970) 1.55
Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab (1997) 1.39
Lines and bands of increased density. Their implication to growth and development. Med Radiogr Photogr (1968) 1.38
Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B. J Clin Invest (1973) 1.35
The relationship of the spiral turns of the cochlea and the length of the basilar membrane to the range of audible frequencies in ground dwelling mammals. J Acoust Soc Am (1985) 1.33
The C3 nephritic factor and membranoproliferative nephritis: correlation of serum levels of the nephritic factor with C3 levels, with therapy, and with progression of the disease. J Pediatr (1972) 1.32
Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis. J Clin Invest (1971) 1.31
The significance of roentgenographic measurement in scoliosis. J Pediatr Orthop (1982) 1.26
Intussusception in the 1970s: indications for operation. J Pediatr Surg (1977) 1.24
Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest (1997) 1.23
The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol (1990) 1.21
Classical complement pathway activation in membranoproliferative glomerulonephritis. Kidney Int (1976) 1.15
Homotransplantation of both kidneys from an anencephalic monster to a 17 pound boy with Eagle-Barret syndrome. Surgery (1969) 1.14
Shunt nephritis: the nature of the serum cryoglobulins and their relation to the complement profile. J Pediatr (1976) 1.13
Transneuronal cell atrophy in the congenitally deaf white cat. J Comp Neurol (1973) 1.12
Transplantation of cadaver kidneys from anencephalic donors. J Pediatr (1978) 1.09
Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III. Am J Kidney Dis (1990) 1.08
Serum immune complexes in membranoproliferative and other glomerulonephritides. Kidney Int (1977) 1.06
Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis. Clin Exp Immunol (1968) 1.06
Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane. Clin Nephrol (1977) 1.04
Cushing's disease with cure by resection of a pituitary adenoma. Evidence against a primary hypothalamic defect. Am J Med (1974) 1.04
Inherited complement component deficiencies in membranoproliferative glomerulonephritis. Kidney Int (1983) 1.04
Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr (1976) 1.04
The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x. J Exp Med (1971) 1.03
Growth and development of children with renal transplants. Use of alternate-day steroid therapy. J Pediatr (1973) 1.03
A serum inhibitor of blastogenesis in idiopathic nephrotic syndrome transferred by lymphocytes. Clin Immunol Immunopathol (1979) 1.03
Unrecognized trauma in infants, the battered child syndrome, and the syndrome of Ambroise Tardieu. Rigler Lecture. Radiology (1972) 1.02
The chronic glomerulonephritides of childhood. Part I. J Pediatr (1978) 1.01
Single-dose metyrapone test. Arch Intern Med (1970) 1.01
A "silent" phase of hypocomplementemic persistent nephritis detectable by reduced serum beta-1c-globulin levels. J Pediatr (1969) 1.01
[Larsen's syndrome: congenital dislocation of the knees and other joints, distinctive facies, and, frequently, cleft palate]. Ann Radiol (Paris) (1972) 0.99
Membranoproliferative hypocomplementemic glomerulonephritis. Nephron (1973) 0.99
Mechanisms of hypocomplementemia in glomerulonephritis. Kidney Int (1973) 0.99
Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr Nephrol (1988) 0.98
A sensitive radioimmunoassay for plasma ACTH levels. J Clin Endocrinol Metab (1966) 0.98
An analgesiometry system for use in rabbits with some preliminary data on the effects of buprenorphine and lofentanil. Lab Anim (1988) 0.97
An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis. Kidney Int (1983) 0.96
Renal homotransplantation in children. Arch Surg (1970) 0.96
Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation. Am J Kidney Dis (1987) 0.95
Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol (1995) 0.95
Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis. Kidney Int (1989) 0.94
A serum thyroxine method: application in thyroid disease and iodine-treated patients. J Clin Endocrinol Metab (1965) 0.94
Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3. Am J Nephrol (1987) 0.94
Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions. Clin Nephrol (1982) 0.94
Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy. J Pediatr (1975) 0.93
Errors in the diagnosis of achondroplasia. Acta Radiol Diagn (Stockh) (1967) 0.93
A simplified metyrapone test with determination of plasma ll-deoxycortisol (Metyrapone test with plasma S). J Clin Endocrinol Metab (1969) 0.93
The effect of null C4 alleles on complement function. Clin Immunol Immunopathol (1985) 0.93
Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course. Nephron (1970) 0.92
Membranoproliferative glomerulonephritis in two sibships. Clin Nephrol (1981) 0.92
Thickness of the normal skull in the American Blacks and Whites. Am J Phys Anthropol (1975) 0.91
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis. Pediatr Clin North Am (1982) 0.91
Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis. Kidney Int (1979) 0.91
Hypocomplementemic and normocomplementemic acute nephritis in children: a comparison with respect to etiology, clinical manifestations, and glomerular morphology. J Pediatr (1974) 0.91
A simple fluorometric method for assay of plasma metyrapone. J Lab Clin Med (1969) 0.91
Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration. Arch Intern Med (1970) 0.90
Asymptomatic hematuria and proteinuria in children: causes and appropriate diagnostic studies. J Pediatr (1976) 0.90
Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy. Perspect Nephrol Hypertens (1973) 0.90
Virus diseases of bone. Do they exist? The Neuhauser Lecture. AJR Am J Roentgenol (1976) 0.89
Recovery from epiphyseal invagination: sequel to an unusual complication of scurvy. J Bone Joint Surg Am (1970) 0.88
A comparison of bioassay and radioimmunoassay for plasma corticotropin in man. J Clin Endocrinol Metab (1972) 0.88
Cushing's syndrome in a patient with an empty sella turcica and a microadenoma of the adenohypophysis. Am J Med (1976) 0.88
Relative value of serum C3 and C4 levels in predicting relapse in systemic lupus erythematosus. Am J Kidney Dis (1991) 0.88
Additional evidence of nuclear emissions during acoustic cavitation. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.87
Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man. J Clin Endocrinol Metab (1969) 0.87
Clinical problems encountered in renal homotransplantation in children. J Pediatr Surg (1970) 0.87
Factors influencing short-term and long-term pediatric renal transplant survival. J Pediatr (1997) 0.87
Clinical spectrum of intrinsic renovascular hypertension in children. Pediatrics (1987) 0.86
A comparison of propofol with other injectable anaesthetics in a rat model for measuring cardiovascular parameters. Lab Anim (1993) 0.86
Plasma 11-deoxycorticosteroid and ACTH response to metyrapone (plasma metyrapone test). J Clin Endocrinol Metab (1969) 0.86
A quantitative study of lipofuscin accumulation with age in normals and individuals with Down's syndrome, phenylketonuria, progeria and transneuronal atrophy. J Comp Neurol (1979) 0.85
IgA synthesis by lymphocytes from patients with IgA nephropathy and their relatives. Kidney Int (1986) 0.85
Cerebro-costo-mandibular syndrome. J Pediatr (1980) 0.85
Childhood membranoproliferative glomerulonephritis: an approach to management. Kidney Int (1986) 0.84
Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis. Clin Exp Immunol (1977) 0.84
A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III. Clin Immunol Immunopathol (1989) 0.84
Clinical and genetic aspects of Conradi-Hünermann disease. A report of three familial cases and review of the literature. J Pediatr (1980) 0.84
Acroosteolysis (Hajdu-Cheney syndrome). Birth Defects Orig Artic Ser (1974) 0.84
Low-dose intravenous insulin infusion versus subcutaneous insulin injection: a controlled comparative study of diabetic ketoacidosis. Pediatrics (1977) 0.84
The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltimore) (1985) 0.84
A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus. J Clin Invest (1985) 0.84
A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone. J Lab Clin Med (1971) 0.83
Atypical hypocomplementemic vasculitis syndrome in a child. J Pediatr (1985) 0.82